Published in Cancer on December 15, 2008
Time-Limited Trials of Intensive Care for Critically Ill Patients With Cancer: How Long Is Long Enough? JAMA Oncol (2016) 1.45
The value of progression-free survival to patients with advanced-stage cancer. Nat Rev Clin Oncol (2011) 1.33
Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices. Oncologist (2010) 1.12
Racial variation in willingness to trade financial resources for life-prolonging cancer treatment. Cancer (2011) 1.04
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials. J Clin Oncol (2015) 0.98
Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study. Trials (2012) 0.94
Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death. J Pain Symptom Manage (2013) 0.90
Functional status declines among cancer survivors: trajectory and contributing factors. J Geriatr Oncol (2014) 0.89
On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points? Ann Oncol (2014) 0.89
Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative. Clin Colorectal Cancer (2011) 0.86
Patient preferences in advanced or recurrent ovarian cancer. Cancer (2014) 0.85
Trajectory of overall health from self-report and factors contributing to health declines among cancer survivors. Cancer Causes Control (2014) 0.84
The impact of misclassification due to survey response fatigue on estimation and identifiability of treatment effects. Stat Med (2011) 0.83
Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo. Gastric Cancer (2014) 0.82
A Web-based communication aid for patients with cancer: the CONNECT Study. Cancer (2013) 0.81
Patient-reported outcomes as end points and outcome indicators in solid tumours. Nat Rev Clin Oncol (2015) 0.80
Provider-based research networks demonstrate greater hospice use for minority patients with lung cancer. J Oncol Pract (2014) 0.80
Patients' and oncologists' views on the treatment and care of advanced ovarian cancer in the U.K.: results from the ADVOCATE study. Br J Cancer (2013) 0.80
Can the Toronto Extremity Salvage Score produce reliable results when used online? Clin Orthop Relat Res (2010) 0.79
Development and cross-validation of the in-hospital mortality prediction in advanced cancer patients score: a preliminary study. J Palliat Med (2012) 0.78
Using surveys to calculate disability-adjusted life-year. Alcohol Res (2013) 0.77
Physician and Patient and Caregiver Health Attitudes and Their Effect on Medicare Resource Allocation for Patients With Advanced Cancer. JAMA Otolaryngol Head Neck Surg (2014) 0.77
Effect of patient and patient-oncologist relationship characteristics on communication about health-related quality of life. Psychooncology (2010) 0.76
Health-Related Quality of Life and Survival of Cholangiocarcinoma Patients in Northeastern Region of Thailand. PLoS One (2016) 0.75
Addressing Patients' Priorities as a Strategy to Improve Value. Oncologist (2016) 0.75
Patient-Centered Outcome Measures in Lung Cancer Trials. Lung (2016) 0.75
Distinct Physical Function Profiles in Older Adults Receiving Cancer Chemotherapy. J Pain Symptom Manage (2017) 0.75
A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care (1996) 70.87
Impact of Event Scale: a measure of subjective stress. Psychosom Med (1979) 21.82
Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med (2004) 10.65
Necessary collusion: prognostic communication with advanced cancer patients. J Clin Oncol (2005) 3.55
The dynamics of change: cancer patients' preferences for information, involvement and support. Ann Oncol (1997) 3.50
Truth may hurt but deceit hurts more: communication in palliative care. Palliat Med (2002) 3.50
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
Effective communication skills are the key to good cancer care. Eur J Cancer (1999) 2.99
Communication styles in the cancer consultation: preferences for a patient-centred approach. Psychooncology (2000) 2.59
Breaking bad news: consensus guidelines for medical practitioners. J Clin Oncol (1995) 2.50
Relationship between preferences for decisional control and illness information among women with breast cancer: a quantitative and qualitative analysis. Soc Sci Med (1994) 2.06
Applying cognitive-social theory to health-protective behavior: breast self-examination in cancer screening. Psychol Bull (1996) 2.04
Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol (2007) 2.04
Breaking bad news about cancer: patients' preferences for communication. J Clin Oncol (2001) 2.00
Enduring impact of communication skills training: results of a 12-month follow-up. Br J Cancer (2003) 1.98
When the diagnosis is cancer: patient communication experiences and preferences. Cancer (1996) 1.82
Information needs in terminal illness. Soc Sci Med (1999) 1.80
Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum (1996) 1.75
Hope and prognostic disclosure. J Clin Oncol (2007) 1.73
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer (2003) 1.65
Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychol (1999) 1.60
Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol (2003) 1.58
How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. J Clin Oncol (2000) 1.52
Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol (2002) 1.49
Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol (2005) 1.26
Preferences of cancer patients regarding the disclosure of bad news. Psychooncology (2007) 1.18
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice. Br J Cancer (2003) 1.08
Building bridges between physicians and patients: results of a pilot study examining new tools for collaborative decision making in breast cancer. J Clin Oncol (2000) 1.07
Discussing adjuvant cancer therapy. J Clin Oncol (2001) 1.02
Tradeoffs between quality and quantity of life: development of the QQ Questionnaire for Cancer Patient Attitudes. Med Decis Making (1996) 1.00
Cancer information needs in rural areas. J Health Commun (2005) 0.92
An exploration of relative health stock in advanced cancer patients. Med Decis Making (2004) 0.90
Biased cognitive processing of cancer-related information among women with family histories of breast cancer: evidence from a cancer stroop task. Health Psychol (2003) 0.90
An Internet method to assess cancer patient information needs and enhance doctor-patient communication: a pilot study. J Cancer Educ (2007) 0.89
Giving bad news to cancer patients: matching process and content. J Clin Oncol (2003) 0.81
Striving for quality or length at the end-of-life: attitudes of the Dutch general public. Patient Educ Couns (2004) 0.80
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol (2007) 11.77
A national evaluation of the effect of trauma-center care on mortality. N Engl J Med (2006) 9.74
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol (2005) 8.56
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol (2011) 5.43
Sedation, alimentation, hydration, and equivocation: careful conversation about care at the end of life. Ann Intern Med (2002) 4.90
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA (2008) 4.61
Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2014) 4.61
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med (2002) 4.42
NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw (2009) 4.41
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2005) 4.10
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology (2009) 3.57
Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. J Urol (2008) 3.46
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol (2009) 3.43
Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol (2009) 3.38
NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw (2009) 3.37
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study. J Clin Oncol (2002) 3.25
Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer (2011) 3.13
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med (2003) 3.01
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg (2009) 2.79
Back to the future: The AMA and religion, 1961-1974. Acad Med (2014) 2.69
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys (2011) 2.54
American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol (2009) 2.52
Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol (2003) 2.52
Academic ranking score: a publication-based reproducible metric of thought leadership in urology. Eur Urol (2011) 2.51
Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol (2013) 2.43
Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol (2009) 2.40
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clin Cancer Res (2011) 2.40
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol (2011) 2.38
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology (2010) 2.35
Perceived discrimination and reported delay of pharmacy prescriptions and medical tests. J Gen Intern Med (2005) 2.25
Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol (2011) 2.22
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer (2003) 2.19
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol (2009) 2.16
The Appalachia Cancer Network: cancer control research among a rural, medically underserved population. J Rural Health (2004) 2.15
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol (2008) 2.15
Discussing religious and spiritual issues at the end of life: a practical guide for physicians. JAMA (2002) 2.11
Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203. J Clin Oncol (2010) 2.10
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin Cancer Res (2007) 2.02
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803. Clin Cancer Res (2009) 2.02
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer. Clin Colorectal Cancer (2002) 2.02
Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer (2011) 1.98
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2012) 1.97
Longitudinal Data with Follow-up Truncated by Death: Match the Analysis Method to Research Aims. Stat Sci (2009) 1.92
Neuroendocrine tumors. J Natl Compr Canc Netw (2012) 1.91
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol (2006) 1.89
Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol (2011) 1.89
The continuum of care: a paradigm for the management of metastatic colorectal cancer. Oncologist (2007) 1.89
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol (2004) 1.86
The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer (2010) 1.84
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol (2012) 1.84
Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma. JAMA (2010) 1.84
Unrealistic optimism in early-phase oncology trials. IRB (2011) 1.75
Exploring the potential of Web 2.0 to address health disparities. J Health Commun (2011) 1.72
Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control (2010) 1.69
Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg (2015) 1.67
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy. J Clin Oncol (2009) 1.65
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer (2003) 1.65
High quality care and ethical pay-for-performance: a Society of General Internal Medicine policy analysis. J Gen Intern Med (2009) 1.65
Relationship of Internet health information use with patient behavior and self-efficacy: experiences of newly diagnosed cancer patients who contact the National Cancer Institute's Cancer Information Service. J Health Commun (2006) 1.65
Response to treatment series: part 2, tumor response assessment--using new and conventional criteria. AJR Am J Roentgenol (2011) 1.64
A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res (2009) 1.64
Is failure to meet spiritual needs associated with cancer patients' perceptions of quality of care and their satisfaction with care? J Clin Oncol (2007) 1.60
Colon cancer, version 3.2014. J Natl Compr Canc Netw (2014) 1.59
Factors affecting recovery of functional status in older adults after cancer surgery. J Am Geriatr Soc (2010) 1.56
Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology (2010) 1.55
Institutional review boards' use and understanding of certificates of confidentiality. PLoS One (2012) 1.53
NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res (2009) 1.53
Pancreatic adenocarcinoma. J Natl Compr Canc Netw (2010) 1.52
The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas (2010) 1.51
Community hospital oversight of clinical investigators' financial relationships. IRB (2009) 1.51
Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw (2015) 1.51
Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research. Circ Cardiovasc Qual Outcomes (2010) 1.50
Validity of a simple ST-elevation acute myocardial infarction risk index: are randomized trial prognostic estimates generalizable to elderly patients? Circulation (2003) 1.50
90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol (2010) 1.49
Bioethics, conflicts of interest, & the limits of transparency. Hastings Cent Rep (2003) 1.49
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract (2013) 1.48
Performance of the Thrombolysis in Myocardial Infarction (TIMI) ST-elevation myocardial infarction risk score in a national cohort of elderly patients. Am Heart J (2005) 1.48
Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU Int (2014) 1.47
Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol (2013) 1.47
Using cognitive interviews to evaluate items for measuring sexual functioning across cancer populations: improvements and remaining challenges. Qual Life Res (2009) 1.46
Developing a simplified consent form for biobanking. PLoS One (2010) 1.45
Baseline functional status may predict decisional regret following robotic prostatectomy. J Urol (2012) 1.45
Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med (2003) 1.45
The other half of the whole: teaching patients to communicate with physicians. Fam Med (2002) 1.44
Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns (2002) 1.44
Using central IRBs for multicenter clinical trials in the United States. PLoS One (2013) 1.43
Barriers to clinical trial participation as perceived by oncologists and patients. J Natl Compr Canc Netw (2007) 1.43
Challenges in enrollment of minority, pediatric, and geriatric patients in emergency and acute care clinical research. Ann Emerg Med (2008) 1.42
Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care. BJU Int (2013) 1.41
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work. Med Care (2015) 1.41
Correlation between financial relationships with commercial interests and research prominence at an oncology meeting. J Clin Oncol (2013) 1.40
Sexual functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS®). Psychooncology (2010) 1.39